Skip to main content

Table 2 Disease severity classification among patients and complications and treatment measures before release from quarantine

From: Epidemiological investigation and intergenerational clinical characteristics of 24 coronavirus disease patients associated with a supermarket cluster: a retrospective study

Characteristics

All patients

(n = 24)

Group

A

(n = 11)

B

(n = 13)

P-value

Disease severity

   

0.776

 Mild (%)

0/24 (0)

0/11 (0)

0/13 (0)

 

 Moderate (%)

23/24 (95.83)

11/11 (100)

12/13 (92.31)

 

 Severe (%)

1/24 (4.17)

0/11 (0)

1/13 (7.69)

 

 Critical (%)

0/24 (0)

0/11 (0)

0/13 (0)

 

Complications

 ARDS (%)

1/24 (4.17)

0/11 (0)

1/13 (7.69)

1

Treatment

 Antibiotics

17/24 (70.83)

9/11 (81.82)

8/13 (61.54)

0.386

 Antifungal drugs

1/24 (4.17)

0/11 (0)

1/13 (7.69)

1

 Antiviral drugs (%)

24/24 (100)

11/11 (100)

13/13 (100)

–

 Glucocorticoids (%)

5/24 (20.83)

2/11 (18.18)

3/13 (23.08)

1

 Albumin (%)

11/24 (45.83)

2/11 (18.18)

9/13 (69.23)

0.019

 Immunoglobulin (%)

6/24 (25.00)

2/11 (18.18)

4/13 (30.77)

0.649

 Thymosin (%)

15/24 (62.50)

7/11 (63.64)

8/13 (61.54)

1

Oxygen therapy (%)

11/24 (45.83)

4/11 (36.36)

7/13 (53.85)

0.444

 Common (%)

10/11 (90.91)

4/4 (100)

6/7 (85.71)

1

 HFNC (%)

1/11 (9.09)

0/4 (0)

1/7 (14.29)

 

TCM (%)

24/24 (100)

11/11 (100)

13/13 (100)

–